Fate Therapeutics (FATE) Long-Term Deferred Tax (2024 - 2025)

Fate Therapeutics (FATE) has 1 years of Long-Term Deferred Tax data on file, last reported at $2.3 million in Q4 2025.

• Quarterly Long-Term Deferred Tax changed N/A year-over-year to $2.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.3 million (changed N/A YoY) and the FY2025 annual result came in at $2.3 million, changed N/A from the prior year.
• Long-Term Deferred Tax held at $2.3 million in Q4 2025.
• In the past five years, Long-Term Deferred Tax ranged from a high of $2.3 million in Q4 2025 to a low of $2.3 million in Q4 2025.